Thrombin stimulates proinflammatory and proliferative responses in primary cultures of human proximal tubule cells

Kidney International

Volumn 67, Issue 4, 2005, Pages 1315-1329

  Vesey, David A ^a   Cheung, Catherine W ^b   Kruger, Wade A ^b   Poronnik, Philip ^b   Gobe, Glenda ^b   Johnson, David W ^b  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b NONE

Author keywords

Fibronectin; Monocyte chemotactic protein 1; Protease activated receptor; Proximal tubule cell; Thrombin; Transforming growth factor beta

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; CELL PROTEIN; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; FIBRONECTIN; FURA 2; ILOMASTAT; LACTATE DEHYDROGENASE; MATRIX METALLOPROTEINASE INHIBITOR; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTRALIZING ANTIBODY; PROTEINASE; PROTEINASE ACTIVATED RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 3; PROTEINASE ACTIVATED RECEPTOR 4; SERYLLEUCYLISOLEUCYLGLYCYLLYSYLVALINAMIDE; SERYLPHENYLALANYLLEUCYLEUCYLARGINYLASPARAGINAMIDE; THREONYLPHENYLALANYLLEUCYLLEUCYLARGINYLASPARAGINAMIDE; THROMBIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE; THYMIDINE; TRANSFORMING GROWTH FACTOR BETA ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ARTICLE; AUTOCRINE EFFECT; BLOOD CLOTTING; CALCIUM MOBILIZATION; CELL DAMAGE; CELL LEVEL; CELL PROLIFERATION; CHRONIC KIDNEY DISEASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DNA SYNTHESIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; FIBRIN DEPOSITION; FLUOROMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INFLAMMATION; KIDNEY CELL CULTURE; KIDNEY FIBROSIS; KIDNEY INTERSTITIUM; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; PRIORITY JOURNAL; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSACTIVATION;

EID: 16244365502     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00209.x     Document Type: Article

References (67)

1. KINCAID-SMITH P: Coagulation and renal disease. Kidney Int 2:183-190, 1972
2. ENESTROM S, DRUID H, RAMMER L: Fibrin deposition in the kidney in post-ischaemic renal damage. Br J Exp Pathol 69:387-394, 1988
3. FAULK WP, GARGIULO P, MCINTYRE JA, et al: Hemostasis and fibrinolysis in renal transplantation. Semin Thromb Hemost 15:88-98, 1989
4. WANG Y, PRATT JR, HARTLEY B, et al: Expression of tissue type plasminogen activator and type 1 plasminogen activator inhibitor, and persistent fibrin deposition in chronic renal allograft failure. Kidney Int 52:371-377, 1997
5. WANG Y, PRATT JR, TAM FW, et al: Up-regulation of type 1 plasminogen activator inhibitor messenger RNA with thrombotic changes in renal grafts. Transplantation 61:684-689, 1996
6. WENDT T, ZHANG YM, BIERHAUS A, et al: Tissue factor expression in an animal model of hydronephrosis. Nephrol Dial Transplant 10:1820-1828, 1995
7. GRANDALIANO G, MONNO R, RANIERI E, et al: Regenerative and proinflammatory effects of thrombin on human proximal tubular cells. J Am Soc Nephrol 11:1016-1025, 2000
8. GRANDALIANO G, GESUALDO L, SCHENA FP: Thrombin: a novel renal growth factor. Exp Nephrol 7:20-25, 1999
9. CHAMBERS RC, LAURENT GJ: Coagulation cascade proteases and tissue fibrosis. Biochem Soc Trans 30:194-200, 2002
10. HOLLENBERG MD, COMPTON SJ, INTERNATIONAL UNION OF PHARMACOLOGY: XXVIII. Proteinase-activated receptors. Pharmacol Rev 54:203-217, 2002
11. OSSOVSKAYA VS, BUNNETT NW: Protease-activated receptors: Contribution to physiology and disease. Physiol Rev 84:579-621, 2004
12. O'BRIEN PJ, MOLINO M, KAHN M, et al: Protease activated receptors: Theme and variations. Oncogene 20:1570-1581, 2001
13. STRUKOVA SM: Thrombin as a regulator of inflammation and reparative processes in tissues. Biochemistry (Mosc) 66:8-18, 2001
14. RONDEAU E, HE CJ, ZACHARIAS U, et al: Thrombin stimulation of renal cells. Semin Thromb Hemost 22:135-138, 1996
15. HE CJ, RONDEAU E, MEDCALF RL, et al: Thrombin increases proliferation and decreases fibrinolytic activity of kidney glomerular epithelial cells. J Cell Physiol 146:131-140, 1991
16. KAUFMANN R, JUNKER U, NUSKE K, et al: PAR-1- and PAR-3-type thrombin receptor expression in primary cultures of human renal cell carcinoma cells. Int J Oncol 20:177-180, 2002
17. GUI Y, LOUTZENHISER R, HOLLENBERG MD: Bidirectional regulation of renal hemodynamics by activation of PARI and PAR2 in isolated perfused rat kidney. Am J Physiol Renal Physiol 285:F95-F104, 2003
18. GRANDALIANO G, DI PAOLO S, MONNO R, et al: Protease-activated receptor 1 and plasminogen activator inhibitor 1 expression in chronic allograft nephropathy: The role of coagulation and fibrinolysis in renal graft fibrosis. Transplantation 72:1437-1443, 2001
19. CUNNINGHAM MA, RONDEAU E, CHEN X, et al: Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis. J Exp Med 191:455-462, 2000
20. YAMABE H, OSAWA H, INUMA H, et al: Thrombin stimulates production of transforming growth factor-beta by cultured human mesangial cells. Nephrol Dial Transplant 12:438-442, 1997
21. WEISS RH, MADURI M: The mitogenic effect of thrombin in vascular smooth muscle cells is largely due to basic fibroblast growth factor. J Biol Chem 268:5724-5727, 1993
22. SHULTZ PJ, KNAUSS TC, MENE P, et al: Mitogenic signals for thrombin in mesangial cells: Regulation of phospholipase C and PDGF genes. Am J Physiol 257:F366-F374, 1989
23. FRUNGIERI MB, WEIDINGER S, MEINEKE V, et al: Proliferative action of mast-cell tryptase is mediated by PAR2, COX2, prostaglandins, and PPARgamma: Possible relevance to human fibrotic disorders. Proc Natl Acad Sci USA 99:15072-15077, 2002
24. RAGOSTA M, BARRY WL, GIMPLE LW, et al: Effect of thrombin inhibition with desulfatohirudin on early kinetics of cellular proliferation after balloon angioplasty in atherosclerotic rabbits. Circulation 93:1194-1200, 1996
25. RADE JJ, SCHULICK AH, VIRMANI R, et al: Local adenoviral-mediated expression of recombinant hirudin reduces neointima formation after arterial injury. Nat Med 2:293-298, 1996
26. NELKEN NA, SOIFER SJ, O'KEEFE J, et al: Thrombin receptor expression in normal and atherosclerotic human arteries. J Clin Invest 90:1614-1621, 1992
27. HERNANDEZ-RODRIGUEZ NA, CAMBREY AD, HARRISON NK, et al: Role of thrombin in pulmonary fibrosis. Lancet 346:1071-1073, 1995
28. JOHNSON DW, BREW BK, PORONNIK P, et al: Transport characteristics of human proximal tubule cells in primary culture. Nephrology 3:183-194, 1997
29. JOHNSON DW, SAUNDERS HJ, BAXTER RC, et al: Paracrine stimulation of human renal fibroblasts by proximal tubule cells. Kidney Int 54:747-757, 1998
30. VESEY DA, CHEUNG CW, CUTTLE L, et al: Interleukin-1beta induces human proximal tubule cell injury, alpha-smooth muscle actin expression and fibronectin production. Kidney Int 62:31-40, 2002
31. CHRISTIANSEN BS, INGERSLEV J, HEICKENDORFF L, et al: Human hepatocytes in culture synthesize and secrete fibronectin. Scand J Clin Lab Invest 48:685-690, 1988
32. 2 release from human respiratory epithelial cells. J Immunol 168:3577-3585, 2002
33. LIU Y, GILCREASE MZ, HENDERSON Y, et al: Expression of protease-activated receptor 1 in oral squamous cell carcinoma. Cancer Lett 169:173-180, 2001
34. RONDEAU E, VIGNEAU C, BERROU J: Role of thrombin receptors in the kidney: Lessons from PAR1 knock-out mice. Nephrol Dial Transplant 16:1529-1531, 2001
35. SABRI A, SHORT J, GUO J, et al: Protease-activated receptor-1-mediated DNA synthesis in cardiac fibroblast is via epidermal growth factor receptor transactivation: Distinct PAR-1 signaling pathways in cardiac fibroblasts and cardiomyocytes. Circ Res 91:532-539, 2002
36. GALDAL KS, EVENSEN SA, NILSEN E: The effect of thrombin on fibronectin in cultured human endothelial cells. Thromb Res 37:583-593, 1985
37. MORII T, FUJITA H, NARITA T, et al: Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy. J Diabetes Comp 17:11-15, 2003
38. LLOYD CM, MINTO AW, DORF ME, et al: RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis. J Exp Med 185:1371-1380, 1997
39. DAI C, LIU Z, ZHOU H, et al: Monocyte chemoattractant protein-1 expression in renal tissue is associated with monocyte recruitment and tubulointerstitial lesions in patients with lupus nephritis. Chin Med J (Engl) 114:864-868, 2001
40. VIEDT C, ORTH SR: Monocyte chemoattractant protein-1 (MCP-1) in the kidney: Does it more than simply attract monocytes? Nephrol Dial Transplant 17:2043-2047, 2002
41. LAFLEUR MA, HOLLENBERG MD, ATKINSON SJ, et al: Activation of pro-(matrix metalloproteinase-2) (pro-MMP-2) by thrombin is membrane-type-MMP-dependent in human umbilical vein endothelial cells and generates a distinct 63 kDa active species. Biochem J 357:107-115, 2001
42. DARMOUL D, GRATIO V, DEVAUD H, et al: Activation of proteinase-activated receptor 1 promotes human colon cancer cell proliferation through epidermal growth factor receptor transactivation. Mol Cancer Res 2:514-522, 2004
43. UCHIYAMA-TANAKA Y, MATSUBARA H, MORI Y, et al: Involvement of HB-EGF and EGF receptor transactivation in TGF-beta-mediated fibronectin expression in mesangial cells. Kidney Int 62:799-808, 2002
44. ZHAO D, ZHAN Y, KOON HW, et al: Metalloproteinase-dependent transforming growth factor-{alpha} release mediates neurotensin-stimulated MAP kinase activation in human colonic epithelial cells. J Biol Chem 279:43547-43554, 2004
45. DREW AF, TUCKER HL, LIU H, et al: Crescentic glomerulonephritis is diminished in fibrinogen-deficient mice. Am J Physiol Renal Physiol 281:F1157-F1163, 2001
46. TIPPING PG, DOWLING JP, HOLDSWORTH SR: Glomerular procoagulant activity in human proliferative glomerulonephritis. J Clin Invest 81:119-125, 1988
47. GANDOSSI E, LUNVEN C, BERRY CN: Role of clot-associated (-derived) thrombin in cell proliferation induced by fibrin clots in vitro. Br J Pharmacol 129:1021-1027, 2000
48. WILNER GD, DANITZ MP, MUDD MS, et al: Selective immobilization of alpha-thrombin by surface-bound fibrin. J Lab Clin Med 97:403-411, 1981
49. REROLLE JP, HERTIG A, NGUYEN G, et al: Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis. Kidney Int 58:1841-1850, 2000
50. ERLICH JH, HOLDSWORTH SR, TIPPING PG: Tissue factor initiates glomerular fibrin deposition and promotes major histocompatibility complex class II expression in crescentic glomerulonephritis. Am J Pathol 150:873-880, 1997
51. MANSELL A, REINICKE A, WORRALL DM, et al: The serine protease inhibitor antithrombin III inhibits LPS-mediated NF-kappaB activation by TLR-4. FEBS Lett 508:313-317, 2001
52. GIUNTOLI DL, RETZINGER GS: Evidence for prothrombin production and thrombin expression by phorbol ester-treated THP-1 cells. Exp Mol Pathol 64:53-62, 1997
53. PEJLER G, LUNDERIUS C, TOMASINI-JOHANSSON B: Macrophages synthesize factor X and secrete factor X/Xa-containing prothrombinase activity into the surrounding medium. Thromb Haemost 84:429-435, 2000
54. HOLLENBERG MD, SAIFEDDINE M, AL ANI B, et al: Proteinase-activated receptors: Structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides. Can J Physiol Pharmacol 75:832-841, 1997
55. CHAMBERS RC, DABBAGH K, MCANULTY RJ, et al: Thrombin stimulates fibroblast procollagen production via proteolytic activation of protease-activated receptor 1. Biochem J 333 (Pt 1):121-127, 1998
56. FERNANDES D, VLAHOS R, STEWART AG: Thrombin-stimulated DNA synthesis in human cultured airway smooth muscle occurs independently of products of cyclo-oxygenase or 5-lipoxygenase. Pulm Pharmacol Ther 13:241-248, 2000
57. KANTHOU C, BENZAKOUR O, PATEL G, et al: Thrombin receptor activating peptide (TRAP) stimulates mitogenesis, c-fos and PDGF-A gene expression in human vascular smooth muscle cells. Thromb Haemost 74:1340-1347, 1995
58. KAUFMANN K, THIEL G: Epidermal growth factor and thrombin induced proliferation of immortalized human keratinocytes is coupled to the synthesis of Egr-1, a zinc finger transcriptional regulator. J Cell Biochem 85:381-391, 2002
59. NAKAGAWA T, KANG DH, OHASHI R, et al: Tubulointerstitial disease: Role of ischemia and microvascular disease. Curr Opin Nephrol Hypertens 12:233-241, 2003
60. KANG YH, KEDAR VP, MAHESHWARI RK: Thrombin stimulation of synthesis and secretion of fibronectin by human A549 epithelial cells and mouse LB fibroblasts. J Histochem Cytochem 39:413-423, 1991
61. GOLDFARB RH, LIOTTA LA: Thrombin cleavage of extracellular matrix proteins. Ann NY Acad Sci 485:288-292, 1986
62. TESCH GH, SCHWARTING A, KINOSHITA K, et al: Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis. J Clin Invest 103:73-80, 1999
63. CARNEY DH, REDIN W, MCCROSKEY L: Role of high-affinity thrombin receptors in postclotting cellular effects of thrombin. Semin Thromb Hemost 18:91-103, 1992
64. NORFLEET AM, BERGMANN JS, CARNEY DH: Thrombin peptide, TP508, stimulates angiogenic responses in animal models of dermal wound healing, in chick chorioallantoic membranes, and in cultured human aortic and microvascular endothelial cells. Gen Pharmacol 35:249-254, 2000
65. HOLLENBERG MD, MOKASHI S, LEBLOND L, et al: Synergistic actions of a thrombin-derived synthetic peptide and a thrombin receptor-activating peptide in stimulating fibroblast mitogenesis. J Cell Physiol 169:491-496, 1996
66. TRAN T, STEWART AG: Protease-activated receptor (PAR)-independent growth and pro-inflammatory actions of thrombin on human cultured airway smooth muscle. Br J Pharmacol 138:865-875, 2003
67. PAGEL CN, DE NIESE MR, ABRAHAM LA, et al: Inhibition of osteoblast apoptosis by thrombin. Bone 33:733-743, 2003